e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
COPD beyond tobacco
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cytokines and immunoglobulins for the prognosis of the work-related chronic bronchitis
S. Lalikov, S. Alexander, R. Tatyana, E. Amelchenko, N. Saevich, O. Omelyanenko (Grodno, Minsk, Belarus)
Source:
Annual Congress 2012 - COPD beyond tobacco
Session:
COPD beyond tobacco
Session type:
Thematic Poster Session
Number:
4006
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Lalikov, S. Alexander, R. Tatyana, E. Amelchenko, N. Saevich, O. Omelyanenko (Grodno, Minsk, Belarus). Cytokines and immunoglobulins for the prognosis of the work-related chronic bronchitis. Eur Respir J 2012; 40: Suppl. 56, 4006
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Clinico-immunological characteristics of acute and exacerbations of chronic bronchitis in youths
Source: Eur Respir J 2003; 22: Suppl. 45, 481s
Year: 2003
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Source: Eur Respir J 2001; 17: 1112-1119
Year: 2001
Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Rheoplasty in chronic bronchitis
Source: Virtual Congress 2021 – Interventional pulmonology
Year: 2021
Dynamics of the inflammatory process by determining the IL-6 content in bronchoalveolar fluid in chronic bronchitis and chronic bronchitis complicated by secondary bronchiectasis
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Localization of respiratory viral antigens in patients with exacerbations of non allergic late-onset asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 411s
Year: 2004
Clinical and inflammatory features of exacerbations of occupational chronic obstructive pulmonary disease
Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction
Year: 2017
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Exacerbation aetiology and inflammation markers in chronic obstructive bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 252s
Year: 2002
Chronic bronchitis: a risk factor for bronchial infection
Source: Eur Respir Monogr 2013; 60: 18-26
Year: 2013
The threat in chronic lung diseases: acute exacerbations
Source: Eur Respir Rev, 26 (145) 170075; 10.1183/16000617.0075-2017
Year: 2017
Chronic bronchitis and plasma markers of inflammation predict incidence of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 681s
Year: 2007
A role of infectious factor in acute exacerbation of chronic obstructive bronchitis and late onset asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 141s
Year: 2001
Symptoms related to asthma and chronic bronchitis in general population
Source: Eur Respir J 2005; 26: Suppl. 49, 379s
Year: 2005
Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema
Source: Eur Respir J 2001; 17: 596-603
Year: 2001
Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Individual risks of developing chronic bronchitis and respiratory symptoms in smokers
Source: Virtual Congress 2021 – Health effects of tobacco and medical professionals
Year: 2021
Lymphocyte subpopulations in serum in patients with nonallergic asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 288s
Year: 2006
Pharmacodynamics of levofloxicin in patients with acute exacerbation of chronic bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002
Clinical relevance of respiratory pathogens in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept